NasdaqGM:MAZEPharmaceuticals
Assessing Maze Therapeutics (MAZE) Valuation After Recent Share Price Weakness And Rich Price To Book Ratio
Maze Therapeutics (MAZE) has drawn attention after recent trading saw the share price close at US$30.38. Returns over the past month and past 3 months have both shown double digit declines.
See our latest analysis for Maze Therapeutics.
The recent weakness, including a 4.19% one day and 36.75% seven day share price decline, comes after a very large 1 year total shareholder return of 166.02%. This suggests that momentum has cooled even as longer term holders remain well ahead.
If Maze's swings...